TITLE

Is screening patients for antibiotic-resistant bacteria justified in the Indian context?

AUTHOR(S)
Bhattacharya, S
PUB. DATE
July 2011
SOURCE
Indian Journal of Medical Microbiology;Jul2011, Vol. 29 Issue 3, p213
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Infection with multi-antibiotic-resistant bacteria is a common clinical problem in India. In some countries and centres, screening patients to detect colonisation by these organisms is used to determine specific interventions such as decolonisation treatment, prophylactic antibiotics prior to surgical interventions or for selection of empirical antibiotic therapy, and to isolate patients so that transmission of these difficult to treat organisms to other patients could be prevented. In India, there is no national guideline or recommendation for screening patients for multi-drug-resistant (MDR) bacteria such as MRSA (methicillin-resistant Staphylococcus aureus), VRE(vancomycin-resistant enterococcus), ESBL (extended spectrum beta-lactamase) or MBL (metallo-beta-lactamase) producers. The present article discusses the relevance of screening patients for multi-antibiotic-resistant bacteria in the Indian context. Literature has been reviewed about antibiotic resistance in India, screening methodology, economic debate about screening. The percentages of strains from various hospitals in India which were reported to be MRSA was between 8 and 71%, those for ESBL between 19 and 60% and carbapenem-resistant Gram-negative bacilli between 5.3 and 59%. There exists culture-based technology for the detection of these resistant organisms from patient samples. For some pathogens, such as MRSA and VRE Polymerase chain reaction-based tests are also becoming available. Screening for MDR bacteria is an option which may be used after appraisal of the resources available, and after exploring possibility of implementing the interventions that may be required after a positive screening test result.
ACCESSION #
65286913

 

Related Articles

  • Decolonisation of MRSA, S. aureus and E. coli by Cold-Atmospheric Plasma Using a Porcine Skin Model In Vitro. Maisch, Tim; Shimizu, Tetsuji; Yang-Fang Li; Heinlin, Julia; Karrer, Sigrid; Morfill, Gregor; Zimmermann, Julia L. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    In the last twenty years new antibacterial agents approved by the U.S. FDA decreased whereas in parallel the resistance situation of multi-resistant bacteria increased. Thus, community and nosocomial acquired infections of resistant bacteria led to a decrease in the efficacy of standard therapy,...

  • Antibacterial Activity and Mechanism of a Scorpion Venom Peptide Derivative In Vitro and In Vivo. Luyang Cao; Chao Dai; Zhongjie Li; Zheng Fan; Yu Song; Yingliang Wu; Zhijian Cao; Wenxin Li // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    BmKn2 is an antimicrobial peptide (AMP) characterized from the venom of scorpion Mesobuthus martensii Karsch by our group. In this study, Kn2-7 was derived from BmKn2 to improve the antibacterial activity and decrease hemolytic activity. Kn2-7 showed increased inhibitory activity against both...

  • Decolonisation of MRSA, S. aureus and E. coli by Cold-Atmospheric Plasma Using a Porcine Skin Model In Vitro. Maisch, Tim; Shimizu, Tetsuji; Yang-Fang Li; Heinlin, Julia; Karrer, Sigrid; Morfill, Gregor; Zimmermann, Julia L. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    In the last twenty years new antibacterial agents approved by the U.S. FDA decreased whereas in parallel the resistance situation of multi-resistant bacteria increased. Thus, community and nosocomial acquired infections of resistant bacteria led to a decrease in the efficacy of standard therapy,...

  • Antibacterial Efficacy Testing of a Bioelectric Wound Dressing Against Clinical Wound Pathogens. Hosan Kim; Makin, Inder; Skiba, Jeff; Ho, Amy; Housler, Greggory; Stojadinovic, Alexander; Izadjoo, Mina // Open Microbiology Journal;2014, Vol. 8, p15 

    Silver-based wound dressings have been developed for the control of bioburden in wounds. However, the popularity and extensive use of silver-based dressings has been associated with emerging microbial resistances to silver. In this study we examined in vitro antibacterial efficacy of a...

  • Testing for MRSA patients.  // McKnight's Long-Term Care News;Mar2010, Vol. 31 Issue 3, p25 

    The article reports on the six-month project in Maine that would require acute-care hospitals to screen high-risk patients for methicillin-resistant staphylococcus aureus (MRSA).

  • Nurses launch swab screening for MSSA.  // Nursing Standard;8/11/2010, Vol. 24 Issue 49, p7 

    The author reports that the Blackpool, Fylde and Wyre, England Hospitals National Health Service Foundation Trust has introduced a rapid screening swab test for methicillin-sensitive staphylococcus aureus (MSSA).

  • In vivo antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic. Li, Guo-Qing; Bai, Xiao-Gang; Li, Cong-Ran; Yang, Xin-Yi; Hu, Xin-Xin; Yuan, Min; Zhang, Wei-Xin; Lou, Ren-Hui; Guo, Hui-Yuan; Jiang, Jian-Dong; You, Xue-Fu // Journal of Antimicrobial Chemotherapy (JAC);Apr2012, Vol. 67 Issue 4, p955 

    Objectives To evaluate the in vivo antibacterial efficacy of chinfloxacin, a novel fluoroquinolone, in murine systemic and local infection models. Methods The efficacy of chinfloxacin in systemic infection was evaluated in a mouse peritonitis model using isolates of methicillin-susceptible...

  • Comparative In Vitro Activity of Grepafloxacin Against Selected Mutants and Clinical Isolates. Soussy, C.J.; Leblanc, F. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p138 

    Evaluates the in vitro activity of grepafloxacin by agar dilution against quinolone-resistant mutants of Gram-negative bacilli and Enterococcus faecalis and their parent strains. Results; Discussion.

  • Ceftaroline for the Treatment of Complicated Skin and Skin-Structure Infections. Liscynesky, Christina; Martin, Stanley I. // Clinical Medicine Reviews in Therapeutics;2012, Vol. 4, p123 

    Ceftaroline is novel "fifth generation" cephalosporin with broad acitivity, most notably including penicillinase-resistant Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus (MRSA). Ceftaroline is inactive against Pseudomonas spp, other gram-negative non-fermenters,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics